Isolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 30, 2013, Pages

  Cléry, Antoine ^a   Sinha, Rahul ^b   Anczuków, Olga ^b   Corrionero, Anna ^c,d   Moursy, Ahmed ^a   Daubner, Gerrit M ^a   Valcárcel, Juan ^c,d   Krainer, Adrian R ^b   Allain, Frédéric H T ^a  

^a ETH ZURICH   (Switzerland)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

NMR; Protein RNA complex; Splicing factor

Indexed keywords

SERINE ARGININE RICH PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN RNA BINDING; PROTEIN STRUCTURE; PSEUDO RNA RECOGNITION MOTIF; REGULATORY MECHANISM; RNA SPLICING; SPLICEOSOME; STRUCTURE ANALYSIS;

NMR; PROTEIN-RNA COMPLEX; SPLICING FACTOR;

AMINO ACID SEQUENCE; ARGININE; BINDING SITES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEINS; RNA; RNA SPLICING; SERINE;

EID: 84880676352     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303445110     Document Type: Article

References (78)

1. Graveley BR (2000) Sorting out the complexity of SR protein functions. RNA 6(9): 1197-1211.
2. Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10(11):741-754.
3. Huang Y, Steitz JA (2005) SRprises along a messenger's journey. Mol Cell 17(5): 613-615.
4. Long JC, Caceres JF (2009) The SR protein family of splicing factors: Master regulators of gene expression. Biochem J 417(1):15-27.
5. Zhong XY, Wang P, Han J, Rosenfeld MG, Fu XD (2009) SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35(1):1-10.
6. Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Biochim Biophys Acta 1792(1):14-26.
7. Soret J, Gabut M, Tazi J (2006) SR proteins as potential targets for therapy. Prog Mol Subcell Biol 44:65-87.
8. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40(12):1413-1415.
9. Wang ET, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221):470-476.
10. Wang GS, Cooper TA (2007) Splicing in disease: Disruption of the splicing code and the decoding machinery. Nat Rev Genet 8(10):749-761.
11. Irimia M, Blencowe BJ (2012) Alternative splicing: Decoding an expansive regulatory layer. Curr Opin Cell Biol 24(3):323-332.
12. Schwerk C, Schulze-Osthoff K (2005) Regulation of apoptosis by alternative premRNA splicing. Mol Cell 19(1):1-13.
13. Bonnal S, et al. (2008) RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell 32(1):81-95.
14. Corsini L, et al. (2007) U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat Struct Mol Biol 14(7):620-629.
15. Förch P, et al. (2000) The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell 6(5):1089-1098.
16. Izquierdo JM, et al. (2005) Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell 19(4):475-484.
17. Cheng J, et al. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263(5154):1759-1762.
18. Bourgeois CF, Lejeune F, Stévenin J (2004) Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. Prog Nucleic Acid Res Mol Biol 78:37-88.
19. Jumaa H, Nielsen PJ (1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J 16(16):5077-5085.
20. Buratti E, Stuani C, De Prato G, Baralle FE (2007) SR protein-mediated inhibition of CFTR exon 9 inclusion: Molecular characterization of the intronic splicing silencer. Nucleic Acids Res 35(13):4359-4368.
21. Gallego ME, Gattoni R, Stévenin J, Marie J, Expert-Bezançon A (1997) The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J 16(7):1772-1784.
22. Han J, et al. (2011) SR proteins induce alternative exon skipping through their activities on the flanking constitutive exons. Mol Cell Biol 31(4):793-802.
23. Jiang ZH, Zhang WJ, Rao Y, Wu JY (1998) Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci USA 95(16): 9155-9160.
24. Lemaire R, Winne A, Sarkissian M, Lafyatis R (1999) SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur J Immunol 29(3):823-837.
25. Solis AS, Peng R, Crawford JB, Phillips JA, 3rd, Patton JG (2008) Growth hormone deficiency and splicing fidelity: Two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically. J Biol Chem 283(35):23619-23626.
26. ten Dam GB, et al. (2000) Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol 164(10):5287-5295.
27. Shen H, Green MR (2004) A pathway of sequential arginine-serine-rich domainsplicing signal interactions during mammalian spliceosome assembly. Mol Cell 16(3): 363-373.
28. Kohtz JD, et al. (1994) Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors. Nature 368(6467):119-124.
29. Wu JY, Maniatis T (1993) Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75(6):1061-1070.
30. Amrein H, Hedley ML, Maniatis T (1994) The role of specific protein-RNA and proteinprotein interactions in positive and negative control of pre-mRNA splicing by Transformer 2. Cell 76(4):735-746.
31. Zhu J, Krainer AR (2000) Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev 14(24):3166-3178.
32. Cho S, et al. (2011) Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc Natl Acad Sci USA 108(20):8233-8238.
33. Manley JL, Krainer AR (2010) A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev 24(11):1073-1074.
34. Ge H, Manley JL (1990) A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62(1):25-34.
35. Krainer AR, Conway GC, Kozak D (1990) The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites. Cell 62(1):35-42.
36. Karni R, et al. (2007) The gene encoding the splicing factor SF2/ASF is a protooncogene. Nat Struct Mol Biol 14(3):185-193.
37. Wang J, Takagaki Y, Manley JL (1996) Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev 10(20):2588-2599.
38. Longman D, Johnstone IL, Cáceres JF (2000) Functional characterization of SR and SRrelated genes in Caenorhabditis elegans. EMBO J 19(7):1625-1637.
39. Chandler SD, Mayeda A, Yeakley JM, Krainer AR, Fu XD (1997) RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins. Proc Natl Acad Sci USA 94(8):3596-3601.
40. Chiodi I, et al. (2004) RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies. Nucleic Acids Res 32(14):4127-4136.
41. Dauksaite V, Akusjärvi G (2004) The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection. Biochem J 381(Pt 2):343-350.
42. Michlewski G, Sanford JR, Cáceres JF (2008) The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Mol Cell 30(2): 179-189.
43. Birney E, Kumar S, Krainer AR (1993) Analysis of the RNA-recognition motif and RS and RGG domains: Conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res 21(25):5803-5816.
44. Cléry A, Blatter M, Allain FH (2008) RNA recognition motifs: Boring? Not quite. Curr Opin Struct Biol 18(3):290-298.
45. Tacke R, Manley JL (1995) The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 14(14):3540-3551.
46. Sanford JR, et al. (2008) Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF. PLoS ONE 3(10):e3369.
47. Tintaru AM, et al. (2007) Structural and functional analysis of RNA and TAP binding to SF2/ASF. EMBO Rep 8(8):756-762.
48. Smith PJ, et al. (2002) An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology 143(1):146-154.
49. Gonçalves V, Matos P, Jordan P (2009) Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum Mol Genet 18(19):3696-3707.
50. Eperon IC, et al. (2000) Selection of alternative 5' splice sites: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol Cell Biol 20(22): 8303-8318.
51. Mayeda A, Krainer AR (1992) Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68(2):365-375.
52. Ding J, et al. (1999) Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA. Genes Dev 13(9):1102-1115.
53. Deka P, Bucheli ME, Moore C, Buratowski S, Varani G (2008) Structure of the yeast SR protein Npl3 and Interaction with mRNA 3'-end processing signals. J Mol Biol 375(1): 136-150.
54. Ngo JC, et al. (2008) A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol Cell 29(5):563-576.
55. Dominguez C, Fisette JF, Chabot B, Allain FH (2010) Structural basis of G-tract recognition and encaging by hnRNP F quasi-RRMs. Nat Struct Mol Biol 17(7):853-861.
56. Hardin JW, Hu YX, McKay DB (2010) Structure of the RNA binding domain of a DEADbox helicase bound to its ribosomal RNA target reveals a novel mode of recognition by an RNA recognition motif. J Mol Biol 402(2):412-427.
57. Pandit S, et al. (2013) Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol Cell 50(2):223-235.
58. Zhou Z, Fu XD (2013) Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122(3):191-207.
59. Sanford JR, et al. (2009) Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res 19(3):381-394.
60. Chen CD, Kobayashi R, Helfman DM (1999) Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat betatropomyosin gene. Genes Dev 13(5):593-606.
61. Jacquenet S, et al. (2001) A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem 276(44):40464-40475.
62. Rothrock CR, House AE, Lynch KW (2005) HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J 24(15):2792-2802.
63. Oh HK, et al. (2013) hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene. Apoptosis 18(7):825-835.
64. Tavanez JP, Madl T, Kooshapur H, Sattler M, Valcárcel J (2012) hnRNP A1 proofreads 3' splice site recognition by U2AF. Mol Cell 45(3):314-329.
65. Erkelenz S, et al. (2013) Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA 19(1):96-102.
66. Cl?ry A, et al. (2011) Molecular basis of purine-rich RNA recognition by the human SRlike protein Tra2-β1. Nat Struct Mol Biol 18(4):443-450.
67. Sattler M, Schleucher J, Griesinger C (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog NMR Spec 34:93-158.
68. Peterson RD, Theimer CA, Wu H, Feigon J (2004) New applications of 2D filtered/edited NOESY for assignment and structure elucidation of RNA and RNA-protein complexes. J Biomol NMR 28(1):59-67.
69. Lee W, Revington MJ, Arrowsmith C, Kay LE (1994) A pulsed field gradient isotopefiltered 3D 13C HMQC-NOESY experiment for extracting intermolecular NOE contacts in molecular complexes. FEBS Lett 350(1):87-90.
70. Herrmann T, Güntert P, Wüthrich K (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319(1):209-227.
71. Herrmann T, Güntert P, Wüthrich K (2002) Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J Biomol NMR 24(3):171-189.
72. Case DA, et al. (2005) The Amber biomolecular simulation programs. J Comput Chem 26(16):1668-1688.
73. Wang JM, Cieplak P, Kollman PA (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21(12):1049-1074.
74. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477-486.
75. Koradi R, Billeter M, Wuthrich K (1996) MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph 14(1):51-55, 29-32.
76. Cáceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR (1997) Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138(2):225-238.
77. Hua Y, Vickers TA, Baker BF, Bennett CF, Krainer AR (2007) Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 5(4):e73.
78. Corrionero A, Raker VA, Izquierdo JM, Valcárcel J (2011) Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease. RNA 17(3):401-411.